2022
DOI: 10.1530/erc-22-0019
|View full text |Cite
|
Sign up to set email alerts
|

Dysregulation of splicing variants and spliceosome components in breast cancer

Abstract: The dysregulation of the splicing process has emerged as a novel hallmark of metabolic and tumor pathologies. In breast cancer (BCa), which represents the most diagnosed cancer type among women worldwide, the generation and/or dysregulation of several oncogenic splicing variants have been described. This is the case of the splicing variants of HER2, ER, BRCA1 or, the recently identified by our group, In1-ghrelin and SST5TMD4, which exhibit oncogenic roles, increasing the malignancy, poor prognosis and resistan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 151 publications
0
3
0
Order By: Relevance
“…Another notable finding emerging from the transcriptional profiles of adenomas was the enrichment of elements associated with spliceosome observed within three ACs (AC1-3), suggesting a potential role of spliceosome pathway in adrenocortical tumourigenesis, as demonstrated in other benign and malignant tumours 7274 .…”
Section: Discussionmentioning
confidence: 89%
“…Another notable finding emerging from the transcriptional profiles of adenomas was the enrichment of elements associated with spliceosome observed within three ACs (AC1-3), suggesting a potential role of spliceosome pathway in adrenocortical tumourigenesis, as demonstrated in other benign and malignant tumours 7274 .…”
Section: Discussionmentioning
confidence: 89%
“…It is widely accepted that cancer cells change the expression pattern of proteins in spliceosomes to regulate tumor-related genes expression, leading to the survival and proliferation of cancer cells [ 34 – 36 ]. Consistently, TNBC alter its certain spliceosomal components and splicing factors to meet the need of development and progression, such as enhanced proliferation, inhibited apoptosis, invasion and metastasis, and angiogenesis [ 32 , 37 ]. For example, apoptosis-related gene Bcl-x contains two isoforms Bcl-xL and Bcl-xS.…”
Section: Discussionmentioning
confidence: 99%
“…Dysregulation of the splicing process and ribosomal modifications are both closely related to tumorigenesis. [76][77][78][79][80] These findings provide insight into the mechanisms underlying the high-risk group of LUAD patients and could potentially lead to the development of targeted therapies to improve prognosis for this group.…”
mentioning
confidence: 94%